Humankind Investments’s iShares Biotechnology ETF IBB Stock Holding History

Humankind Investments’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.51M	Hold	50,000	–	–	4.55%	9
2026 Q1	$8.44M	Sell	50,000 -4,500	-8%	-$769K	4.82%	9
2025 Q4	$9.2M	Buy	54,500 +50,000	+1,111%	+$8.12M	4.13%	10
2025 Q3	$650K	Hold	4,500	–	–	0.15%	73
2025 Q2	$569K	Hold	4,500	–	–	0.14%	78
2025 Q1	$576K	Hold	4,500	–	–	0.15%	79
2024 Q4	$595K	Hold	4,500	–	–	0.15%	75
2024 Q3	$655K	Hold	4,500	–	–	0.24%	62
2024 Q2	$618K	Hold	4,500	–	–	0.16%	68
2024 Q1	$617K	Hold	4,500	–	–	0.16%	68
2023 Q4	$611K	Buy	+4,500	New	+$549K	0.18%	65

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Humankind Investments's IBB Position: Q2 2026 in Review

Humankind Investments held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 50,000 shares worth $9.51M. The position accounts for 4.55% of the portfolio, ranked #9.

Humankind Investments first reported a position in IBB in Q4 2023 and has held it in 11 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Humankind Investments held 50,000 shares of iShares Biotechnology ETF worth $9.51M as of Q2 2026.
Humankind Investments left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 4.55% of Humankind Investments's portfolio in Q2 2026, its #9 holding.
Humankind Investments first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 11 quarters since.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Humankind Investments's 13F filing for Q2 2026, filed 14 Aug 2026.